Kadcyla (ado-trastuzumab emtansine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kadcyla (ado-trastuzumab emtansine), covering 2025-05-13 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy [Phase 3]